Arcutis Biotherapeutics, Inc. (ARQT) › Capital ExpendituresArcutis Biotherapeutics, Inc. (ARQT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $02019: $295.0K2020: $321.0K2021: $995.0K2022: $333.0K2023: $428.0K2024: $143.0K2025: $686.0K$686.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$686.0K+379.7%2024$143.0K-66.6%2023$428.0K+28.5%2022$333.0K-66.5%2021$995.0K+210.0%2020$321.0K+8.8%2019$295.0K—2018$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share